Personalized medicine-based strategy for prostate cancer

With the emergence of molecularly targeted drugs, the phrase “personalized medicine” has recently become frequently used in the medical community. This phrase basically refers to treatments based on the selection of optimum therapies for individual patients but it can also include treatments based on the integration of various new technologies to enhance clinical care. Interest in personalized medicine will likely continue to increase in the future. Given the rapid advances in molecular biology, genetic engineering, biotechnology, and related sciences, personalized medicine is closer to realization but continues to face many issues.

In recent years, the word “strategy” has become an everyday term, especially in phrases such as “management strategy” and “government strategy”. Strategy generally refers to the art or science of coordinated effort and resource management with a long-term perspective and a multifaceted approach in order to reach a specific goal. When translated into the specific context of medical treatment, strategy refers to the methods of preparing, planning, and managing medical treatment from a long-term and overall perspective and would thus seem to be distinct from medical practice, which represents the concrete execution of strategy. Because strategy will likely hold particular importance in the field of personalized medicine, I would like to present an overview of strategy in this field and also draw on my own experience.